Tech Titans and Pharma Power: Top Movers Surging with Robust Earnings

1. Monolithic Power Systems (Nasdaq: MPWR)
Monolithic Power Systems surged by 11.42%. Monolithic Power reported first-half revenue of $965 million for fiscal 2024, with net income of $193 million, down 7.83% year-over-year. Needham, Truist Securities, and Rosenblatt maintain buy ratings with price targets of $1000, $918, and $880, respectively.

2. Palantir Technologies (NYSE: PLTR)
Palantir Technologies surged by 11.21%. Palantir reported Q2 2024 revenue of $1.312 billion, up 23.99% year-over-year. Goldman Sachs maintained a neutral rating with a price target of $16.00. Raymond James maintained an outperform rating with a price target of $30.00. RBC Capital reiterated an underperform rating with a $9.00 target.

3. Parker-Hannifin (NYSE: PH)
Parker-Hannifin surged by 10.84%. Parker-Hannifin reported Fourth Quarter fiscal 2024 results on August 8, 2024. Parker-Hannifin's Third Quarter 2024 earnings showed revenue of $14.743 billion and net profit of $2.06 billion. Stifel, Wells Fargo, Truist Securities, and Raymond James have positive ratings with target prices of $613, $600, $621, and $610, respectively.

4. Arm Holdings Plc (Nasdaq: ARM)
Arm Holdings Plc surged by 10.59%. Arm Holdings posted Q1 2025 earnings with revenue of $9.39 billion and net profit up 112.38% to $223 million. Various analysts including Daiwa, Bernstein, Loop Capital, and Rosenblatt have upgraded or maintained ratings, raising price targets citing strong AI demand.

5. Eli Lilly Andmpany (NYSE: LLY)
Eli Lilly Andmpany surged by 9.38%. Eli Lilly reported second-quarter fiscal 2024 net income rose nearly 70%, driven by $12 billion in revenue from its weight-loss drug. The company raised its full-year revenue guidance by $3 billion, now expecting $454-$466 billion.